18F-Thretide PET/CT 检出透明细胞肾细胞癌小脑转移
Detection of Small Brain Metastases by 18 F-Thretide PET/CT in Clear Cell Renal Cell Carcinoma.
PubMed 文献 · Clin Nucl Med · 2024-10-30
一名46岁女性透明细胞肾细胞癌根治性肾切除术后患者,先后行18F-FDG PET/CT与18F-Thretide(Al18F-PSMA-BCH)PET/CT;18F-FDG PET/CT未检出脑转移,18F-Thretide PET/CT检出右小脑1.0×0.7 cm与右额叶0.4 cm两处小转移灶,后经脑MRI证实。
要点
- 18F-FDG PET/CT未检出脑转移,18F-Thretide PET/CT检出右小脑1.0×0.7 cm及右额叶0.4 cm两处转移灶。
- 两处18F-Thretide PET/CT所示转移灶后经脑MRI证实。
- 患者为46岁女性,因透明细胞肾细胞癌行根治性肾切除术。
核心结论
- 18F-Thretide PET/CT在18F-FDG PET/CT未检出脑转移的情况下检出2处小脑转移灶,并均经脑MRI证实。
研究设计与样本
- 病例报告:一名46岁女性透明细胞肾细胞癌根治性肾切除术后患者,先后行18F-FDG PET/CT与18F-Thretide(Al18F-PSMA-BCH)PET/CT。
主要发现
- 18F-FDG PET/CT未检出任何脑转移灶。
- 18F-Thretide PET/CT检出2处小转移灶:右小脑1.0×0.7 cm,右额叶0.4 cm。
- 上述转移灶后经脑MRI证实。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 46-year-old woman with a history of radical nephrectomy for clear cell renal cell carcinoma underwent 18 F-FDG and 18 F-Thretid (also known as Al 18 F-PSMA-BCH) PET/CT. Although the 18 F-FDG PET/CT failed to detect any brain metastases, the 18 F-Thretide PET/CT revealed 2 small metastases: one measuring 1.0 × 0.7 cm in the right cerebellum and the other measuring 0.4 cm in the right frontal lobe. These metastatic lesions were subsequently confirmed by brain MRI.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Cheng X, Hou G, Zheng R, et al. Detection of Small Brain Metastases by 18 F-Thretide PET/CT in Clear Cell Renal Cell Carcinoma. Clin Nucl Med. 2024. PMID: 39480242. doi:10.1097/RLU.0000000000005523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。